Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Open House Biologika Discount Contracts 2025 01 Infliximab

Deadline: 31 Mar 2027

Germany

Ref. No.: 13340893

EMD:Ref Document

Bid Value: Ref Document

524 Days Left

Construction Team For Drug Residue Removal At Woerden Wwtp

Deadline: 01 Jan 2028

Netherlands

Ref. No.: 13259787

EMD:Ref Document

Bid Value: Ref Document

800 Days Left

Open House Drug Discount Agreements For The Active Ingredient Opipramol Atc N06Aa05

Deadline: 30 Nov 2025

Germany

Ref. No.: 13243919

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Dynamic Procurement System For Pharmaceuticals

Deadline: 01 Dec 2026

Germany

Ref. No.: 12890337

EMD:Ref Document

Bid Value: Ref Document

404 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Oxycodone Naloxone Atc Code According To Who N02Aa55

Deadline: 31 Mar 2027

Germany

Ref. No.: 12805200

EMD:Ref Document

Bid Value: Ref Document

524 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Beclometasone Formoterol Atc Code According To Who R03Ak08

Deadline: 30 Nov 2025

Germany

Ref. No.: 12712311

EMD:Ref Document

Bid Value: Ref Document

38 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Dornase Alfa Atc Code According To Who R05Cb13

Deadline: 31 Mar 2027

Germany

Ref. No.: 12678054

EMD:Ref Document

Bid Value: Ref Document

524 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Aripiprazole For Parenteral Administration Atc Code According To Who N05A

Deadline: 31 Mar 2027

Germany

Ref. No.: 12644757

EMD:Ref Document

Bid Value: Ref Document

524 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Natalizumab Atc Code According To Who L04Ag03

Deadline: 30 Nov 2026

Germany

Ref. No.: 12638948

EMD:Ref Document

Bid Value: Ref Document

403 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V In The Period From 01 03 2025 To 31 12 2026

Deadline: 10 Nov 2026

Germany

Ref. No.: 12632408

EMD:Ref Document

Bid Value: Ref Document

383 Days Left

Open House Drug Discount Agreements Nilotinib Atc L01Ea03 Excluding Nilotinib Dispersed In Apple Sauce Unless The Manufacturer Enjoys Patent Protection For This

Deadline: 05 Jan 2027

Germany

Ref. No.: 12611391

EMD:Ref Document

Bid Value: Ref Document

439 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V On Active Ingredients Medicines Vv 81

Deadline: 10 Feb 2027

Germany

Ref. No.: 12608542

EMD:Ref Document

Bid Value: Ref Document

475 Days Left

Open House Biologics Discount Agreements 2025 02 Rituximab Subcutaneous Injection Dosage Form

Deadline: 01 Mar 2027

Germany

Ref. No.: 12569301

EMD:Ref Document

Bid Value: Ref Document

494 Days Left

Open House Drug Discount Agreements Nilotinib Atc L01Ea03 Excluding Nilotinib Dispersed In Apple Sauce Unless The Manufacturer Enjoys Patent Protection For This

Deadline: 05 Jan 2027

Germany

Ref. No.: 12487341

EMD:Ref Document

Bid Value: Ref Document

439 Days Left

Open House Drug Discount Agreements Botulinum Toxin Type A Finished Medicinal Product Name Xeomin R Atc M03Ax21

Deadline: 05 Jan 2027

Germany

Ref. No.: 12368970

EMD:Ref Document

Bid Value: Ref Document

439 Days Left

Showing 46006 to 46020 of 46477 results

‹
1
2
...
3065
3066
3067
3068
3069
3070
3071
...
3098
3099
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!